- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 42.78M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $127.53M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $127.54M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $155.51M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $147.09M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $166.31M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $160.3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $369.34M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $349.63M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $503.49M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $483.59M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $628.34M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $597.33M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $837.16M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $806.85M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 41.92M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.07M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.43M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $303.37M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $303.72M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.16 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.16 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $14.67M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.14M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $269.89M |
| Revenue | Q1 2025 · Mar 31, 2024 | $306.12M |